罗沙沙斯塔特对降低腹腔透析患者贫血血的血脂的作用
Tian Xu1, Yilin Ruan1, Na Liu2
1Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Renal failure
|February 25, 2025
概括
在腹膜透析患者中,罗沙杜沙特治疗显著降低了血脂,包括总胆固醇和甘油三,与红素相比. 这表明roxadustat提供了超越贫血管理的好处.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 腹腔透析 (PD) 患者经常经历贫血和脂质不良.
- 红色发育刺激剂 (ESA) 是PD贫血的标准,但脂质效应的理解较少.
- 作为一种新的贫血治疗方法,Roxadustat可能会影响脂质代谢.
研究的目的:
- 评估roxadustat对PD患者血脂水平的影响.
- 在贫血的PD患者中,将roxadustat的降脂效应与红色素 (EPO) 进行比较.
- 评估roxadustat对超出贫血纠正的代谢参数的更广泛影响.
主要方法:
- 一项前性多中心研究随机分配了100名PD患者,在48周内接受罗沙沙斯塔特或EPO.
- 患者在入学前至少接受了4周的ESA治疗.
- 在整个研究期间,对血脂,血红蛋白,铁代谢和其他因素进行了监测.
主要成果:
- 与EPO相比,Roxadustat治疗导致48周内总胆固醇,LDL胆固醇和甘油三水平显著降低.
- 虽然最初在roxadustat治疗时血红蛋白的增加略快,但在两组之间没有观察到显著的长期差异.
- 在研究初期,roxadustat组中,转林和率显著下降.
结论:
- 罗沙杜沙特在降低PD患者血清胆固醇和甘油三水平方面表现出有效性.
- 这些发现表明,roxadustat提供了双重好处:管理贫血和改善脂质配置文件.
- 切换从EPO到roxadustat可能是一个可行的策略,PD患者患有脂质失调.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
509
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
509
01:11Renal Failure: Dose Adjustments
54
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
54
01:27Dialysis
249
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
249
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
370
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
370
01:29Cholesterol: Significance and Regulation
496
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
496
01:17Factors Affecting Renal Clearance: Renal Impairment
48
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
48